In 2002 was created WestRiver Group, LLC, which is appeared as VC. The venture was found in North America in United States. The main office of represented VC is situated in the Kirkland.
The average startup value when the investment from WestRiver Group, LLC is 50-100 millions dollars. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 36 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2019. This WestRiver Group, LLC works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the WestRiver Group, LLC, startups are often financed by Madrona Venture Group, Ignition Partners, Sigma Partners. The meaningful sponsors for the fund in investment in the same round are Madrona Venture Group, Sigma Partners, Ignition Partners. In the next rounds fund is usually obtained by Sigma Partners, Salesforce Ventures, Ignition Partners.
The current fund was established by Erik Anderson. We also calculated 3 valuable employees in our database.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DocuSign, Cardiac Dimensions, Pro.com. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Enterprise Software.
| Fund Name | Location |
| 212 Ventures | New York, New York, United States |
| Argus Capital | England, London, United Kingdom |
| Bajaj Allianz Life Insurance Company Limited | India, Maharashtra, Pune |
| Big Block Media | - |
| Biotechnology Development Fund VI, L.P. | California, Palo Alto, United States |
| Charles Schwab | California, San Francisco, United States |
| CompStak | New York, New York, United States |
| Dongrun Xinyuan Keji | - |
| Earth Space Robotics | - |
| ESA Business Applications | Oxford, Oxfordshire, United Kingdom |
| JIC Capital | Beijing, Beijing, China |
| Kaopu Wangluo | China, Foochow, Fujian |
| KRR | - |
| RSC Capital | New York, New York, United States |
| Seraphim Capital | England, London, United Kingdom |
| Sinochem International | China, Shanghai |
| State Street | Boston, Massachusetts, United States |
| Vision Japan | Chiyoda, Japan |
| Vostok Ventures | Kyiv, Ukraine, Київська міська громада |
| WMG Investments | California, Los Angeles, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Viome | $86M | 18 Aug 2023 | Bellevue, Washington, United States | ||
Groopit | $3M | 18 May 2023 | Seattle, Washington, United States | ||
Colossal Biosciences | $150M | 31 Jan 2023 | Dallas, Texas, United States | ||
Viome | $67M | 15 Oct 2022 | Bellevue, Washington, United States | ||
CHEQ | $8M | 21 Sep 2022 | Bellevue, Washington, United States | ||
Tagboard | $2M | 12 Apr 2022 | Redmond, Washington, United States | ||
PTO Exchange | $5M | 03 Mar 2022 | Washington, United States | ||
Viome | $54M | 10 Nov 2021 | Bellevue, Washington, United States | ||
Design Therapeutics | $125M | 27 Jan 2021 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Viome | $86M | 18 Aug 2023 | Bellevue, Washington, United States | ||
Groopit | $3M | 18 May 2023 | Seattle, Washington, United States | ||
Colossal Biosciences | $150M | 31 Jan 2023 | Dallas, Texas, United States | ||
Viome | $67M | 15 Oct 2022 | Bellevue, Washington, United States | ||
CHEQ | $8M | 21 Sep 2022 | Bellevue, Washington, United States | ||
Tagboard | $2M | 12 Apr 2022 | Redmond, Washington, United States | ||
PTO Exchange | $5M | 03 Mar 2022 | Washington, United States | ||
Viome | $54M | 10 Nov 2021 | Bellevue, Washington, United States | ||
Design Therapeutics | $125M | 27 Jan 2021 | California, United States |
